Safeguard Scientifics, Inc. engages in the provision capital to technology-driven businesses in healthcare, financial services, and digital media. The company is headquartered in Radnor, Pennsylvania. The firm offers strategic, operational and management support to certain of its ownership interests, which include defining short and long-term strategic goals; identifying and planning for the critical success factors to reach these goals; identifying and addressing the challenges and operational improvements required to achieve the critical success factors and, ultimately, the strategic goals; identifying and implementing the business measurements that the Company and others are apply to measure a company’s success; and identifying sources of and providing capital to drive growth. The company also continues to hold relatively small equity interests in other enterprises where it does not exert significant influence and do not participate in management activities. The firm's subsidiaries include Bonfield VII, Ltd., Safeguard Delaware, Inc., SFE Properties, Inc., and others.
Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for SFES. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: SFES is a Buy candidate.
SFES stock price ended at $0.76 on 金曜日, after dropping 1.30%
On the latest trading day Jan 16, 2026, the stock price of SFES fell by 1.30%, dropping from $0.74 to $0.76. During the session, the stock saw a volatility of 2.70%, with prices oscillating between a daily low of $0.74 and a high of $0.76. On the latest trading day, the trading volume for SFES decreased by 19.5K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 69.2K shares were traded, with a market value of approximately $12.7M.